Recent Material Events - Obagi Medical Products, Inc (OMPI)

Filing Date	Description
2008-08-11	Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ...
2008-06-23	On June 18, 2008, the Board of Directors of Obagi Medical Products, Inc. (the “Company”) appointed Preston Romm as the Company’s new Chief Financial Officer, Executive Vice President, Finance, Operations and Administration, and Treasur ...
2008-05-06	On April 30, 2008, OMP, Inc. (the “Company”), a wholly owned subsidiary of Obagi Medical Products, Inc., entered into a lease agreement (the “Lease”) with Kilroy Realty, L.P. for the lease of office space located at 3760 Kilroy Ai ...
2008-04-11	(e) On April 8, 2008, the Compensation Committee of the Board of Directors of Obagi Medical Products, Inc. (the “ Company ”) approved the Obagi System 2008 Performance Incentive Plan (the “ Plan ”), an incentive compensation progr ...
2008-03-07	On March 3, 2008, OMP, Inc. (the “Company”) entered into an amendment (the “Amendment”) to its employment agreement with Steven Robert Carlson, the Company’s President and Chief Executive Officer, effective as of March 1, 200 ...
2008-03-03	On March 3, 2008, Obagi Medical Products, Inc. issued a press release announcing financial results for the year ended December 31, 2007. A copy of the press release is attached hereto as Exhibit 99.1, which is incorporated herein by reference. ...
2008-02-29	Second Amended and Restated Bylaws of Obagi Medical Products, Inc., as amended and restated on February 27, 2008 ...
2007-12-14	On December 10, 2007, Bradley J. Hoecker, a member of the Board of Directors (the “Board”) of Obagi Medical Products, Inc. (the “Company”), announced his intention to resign effective December 12, 2007. Mr. Hoecker resigned from h ...
2007-11-13	On November 13, 2007, Obagi Medical Products, Inc. issued a press release announcing financial results for the third quarter ended September 30, 2007. A copy of the press release is attached hereto as Exhibit 99.1, which is incorporated herein by ref ...
2007-10-01	The information provided pursuant to this Item 7.01 shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or incorporated by reference into those filings of Obagi Medica ...